논문KCI 등재
Screening of patients at high risk of de novo recurrence in HCC: Editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (17)
관련 논문AI추천
Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”Kwang-Woong Lee, Young-Joon Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early- stage hepatocellular carcinoma”Chien-Wei Su, Chun-Ting Ho, Elise Chia-Hui Tan대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinomaDa-Won Kim, Jin Hyun Park, Jin-Young Lee, Ji-One Pyeon, Kwang-Woong Lee, Kyung-Suk Suh, Min-Hyeok Jung, Nam-Joon Yi, Suk Kyun Hong, Young-Joon Kim, YoungRok Choi대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”Chien-Wei Su, Chun-Ting Ho, Elise Chia-Hui Tan대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on “Conventional and machine learning- based risk scores for patients with early-stage hepatocellular carcinoma”Grace Lai-Hung Wong, Jimmy Che-To Lai, Junlong Dai, Terry Cheuk-Fung Yip대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133